Go Back
Lantheus Holdings, Inc. reports $2.8 million Q1 loss
By USInMinutes - May 04, 2023, 10:52 AM ET
Last Updated - Jul 18, 2023, 03:40 PM EDT
The company generated $300.80 million in quarterly revenue
Lantheus Holdings, Inc. [LNTH] has reported fiscal Q1 loss of $2.80 million.
On a per-share basis, the DE based company said its diluted earnings are $0.04 .
The In Vitro & In Vivo Diagnostic Substances firm posted revenue of $300.80 million in this period.
Also Read:
- Lantheus Reports First Quarter 2023 Financial Results
- Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for177Lu-PNT2002 for ...
- Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for¹⁷⁷Lu-PNT2002 for ...
- Lantheus to Host First Quarter 2023 Earnings Conference Call and Webcast on May 4, 2023, at ...
- Navidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News